Musculoskeletal System Disorders Market Size Projected to Rise Lucratively during 2021 2030

In a recent published report, Kenneth Research has updated the market report for Musculoskeletal System Disorders Market  for 2021 till 2030. Report further now discusses; the various strategies to be adopted or being adopted by the business players across the globe at various levels in the value chain. In the view of the global economic slowdown, we further estimated that China, India, Japan and South Korea to recover fastest amongst all the countries in the Asian market. Germany, France, Italy, Spain to take the worst hit and this hit is expected to be regain 25% by the end of 2021- Positive Growth in the economic demand and supply.

U.S. Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analsysis and U.S. Census Bureau mentions the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4 billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) avergae exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilest imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Musculoskeletal System Disorders Market  products.

The Global Musculoskeletal System Disorders Market is expected to cross USD 5.73 Billion by 2025 at a CAGR of 5.3%.The number of musculoskeletal system disorder cases is increasing globally, fueling market growth. Musculoskeletal system disorders are the second-highest contributor to global disability and an estimated 20%–33% of people across the globe live with a painful musculoskeletal condition.Musculoskeletal disorders are most common in low- and middle-income countries and these disorders require lifelong care to manage.

Download Sample of This Strategic Report-

Market Influencer

Rising prevalence of musculoskeletal disorders and increasing reimbursement offered to patients by health insurance providers.

Market Drivers

Growing global geriatric population.

Change in lifestyle habits leading to bad posture, which is increasing the prevalence of musculoskeletal system disorders.Increasing research and development of new drugs to treat musculoskeletal disorders. For instance, in 2017–2018, the National Institute of Health Research (NIHR) spent approximately USD 13.46 million (GBP 11.1 million) on research on musculoskeletal disorders.

Rising prevalence of work-related musculoskeletal disorders. For example, the prevalence in the fiscal year 2017–2018 was about 469,000 in the UK.Rising awareness of advanced treatment for musculoskeletal disorders.Launch of new medication to manage the symptoms of chronic musculoskeletal system disorders.

Market Restraints

High treatment costs.

Availability of alternative therapies such as traditional medicine and physiotherapy.Need for specialized equipment to diagnose and treat musculoskeletal system disorders.

Recently, a significant growth in healthcare spending have been observed in the low- and middle-income nations. In the middle-income nations, healthcare spending rose by 6.3% a year between 2000 and 2017, while the economy rose by 5.9% a year. Additionally, health spending in low-income countries also observed a growth by 7.8% a year in the same period. The growth in the healthcare spending of these nations can be attributed to the increasing focus of the governments in these nations to meet the laid down targets of the Sustainable Development Goals (SDGs) of 2030. Such factors are anticipated to drive the growth of the MARKET during the forecast period.


By Type

Rheumatoid Arthritis: The largest segment of the market, rheumatoid arthritis afflicts almost 1% of the entire global population and is three times as likely to afflict women than men.Osteoarthritis: This disorder generally afflicts elderly people. As of 2018, about 9.6% of men and 18% of women over 60 had symptomatic osteoarthritis worldwide and over a quarter of those afflicted could not perform daily activities.

Download Sample of This Strategic Report-

Osteoporosis: The fastest-growing segment, over 75 million people suffer from osteoporosis in Europe, the US, and Japan. This number is growing in developing countries and the disorder is responsible for millions of fractures worldwide. By 2050, osteoporosis is expected to be responsible for a 310% increase in hip fractures for men and a 240% increase for women, as compared to rates in 1990.

Psoriatic Arthritis: This autoimmune disorder afflicts roughly 3 out of every 10 individuals who have psoriasis. With over 100 million people afflicted globally with psoriasis, psoriatic arthritis afflicts almost 30 million individuals.

Ankylosing Spondylitis: The tendency to develop this condition is genetic, with males twice to three times more likely to be afflicted than women.Fibromyalgia: A very common ailment, about 80%–90% of sufferers of fibromyalgia are women.Others: This segment covers musculoskeletal disorders such as tendinitis and carpal tunnel syndrome.

By Treatment

Biologics: The fastest-growing segment, biologics find increasing application in the treatment of rheumatoid arthritis. A rise in the number of FDA approvals for biologics to treat musculoskeletal system disorders is a key factor for the growth of the segment.

Request For Full Report-

Corticosteroids: The largest segment, corticosteroids are the preferred treatment for many musculoskeletal system disorders as they reduce inflammation and suppress immune system activity.

Physical Therapy: Used to manage almost all chronic musculoskeletal system disorders, physical therapy is prescribed in conjunction with medication.

Extracorporeal Shock Wave Therapy: Used to manage pain, this therapy excels in providing fast-acting relief without the use of painkillers. Used extensively in managing musculoskeletal system disorders.

Protein Therapy: A novel method used to combat several musculoskeletal system disorders; it involves the ingestion of protein via changes in diet and artificially produced proteins.

Synthetic Bone Graft: An expensive and complex treatment option, synthetic bone grafts have been used to replace bones made too brittle by osteoporosis and other musculoskeletal system disorders.

Composite Grafts: Used for several bone replacement and repair procedures.

Request For Full Report-

Demineralized Bone Matrix: The treatment method is used in bone transplants where the biological activity of the graft is more important than its mechanical properties.

Others: This segment covers alternative treatment methods such as gene therapy and chiropractic care.

By End User

Hospitals and Clinics: The largest segment, hospitals and clinics are usually the primary points for diagnosis, treatment, and rehabilitation of individuals afflicted with musculoskeletal system disorders. Growing awareness and increasing efficiency of musculoskeletal system disorder treatment are projected to drive the growth of this segment during the forecast period.

Ambulatory Surgical Centers: A small segment, these centers provide immediate pain relief and rudimentary surgical care.

Others: This segment includes home care and senior citizen centers.

By Region

Americas: The largest regional market, the prevalence of musculoskeletal system disorders is high in the Americas; the region also has a well-established healthcare industry.

Europe: An increasing geriatric population is leading to a rise in the number of musculoskeletal system disorder cases.

Asia-Pacific: The fastest-growing regional market, Asia-Pacific is seeing a surge in the number of people afflicted with musculoskeletal system disorders due to bad posture brought on by lifestyle changes, aging, and genetic predisposition.

Request For Full Report-

Middle East & Africa: The smallest market due to limited healthcare infrastructure and a very young population.

Key Players

AB Science (France)

AbGenomics International, Inc. (US)

Alder BioPharmaceuticals,Inc. (US)

Amgen Inc. (US)

Lexicon Pharmaceuticals, Inc. (US)

LG Chem (South Korea)

OrthoTrophix, Inc. (US)

Tarsa Therapeutics, Inc. (US)

PhytoHealth Corporation (Taiwan)

Eisai Co., Ltd (Japan)

Astellas Pharma Inc. (Japan)

AstraZeneca (UK)

Baxter (US)

GlaxoSmithKline PLC (UK)

About Kenneth Research:

Kenneth Research provides market research reports to different individuals, industries, associations and organizations with an aim of helping them to take prominent decisions. Our research library comprises of more than 10,000 research reports provided by more than 15 market research publishers across different industries. Our collection of market research solutions covers both macro level as well as micro level categories with relevant and suitable market research titles. As a global market research reselling firm, Kenneth Research provides significant analysis on various markets with pure business intelligence and consulting services on different industries across the globe. In addition to that, our internal research team always keep a track on the international and domestic market for any economic changes impacting the products’ demand, growth and opportunities for new and existing players.

Contact Us

Kenneth Research
Email: [email protected]
Phone: +1 313 462 0609

Automated Sortation System Market
IRIS Recognition Market
Digital TV Market
Telehealth Market
Ambient Assisted Living Market
Human Augmentation Market
Function as a Service Market

Share your love
Christophe Rude

Christophe Rude

Articles: 15890

Leave a Reply

Your email address will not be published. Required fields are marked *